arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Collegium Pharmaceutical, Inc.

COLL Health Care Biotechnology: Pharmaceutical Preparations
$23.53
Today
as of Sep 4, 16:47 ET
Last 30 days -34.46% Jul 28 → Sep 04
$22.51 $26.21 $29.91 $33.61 $37.31 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$23.54
High
$24.32
Low
$23.37
Volume
$884,072
Avg Vol
$512,144
Mkt Cap
$916M
P/E (TTM)
—
Beta
—
52w High
$50.79
52w Low
$23.37
Div Yield
—
Shares Out
$32M

Recent Press Releases & News last 60 days · 21 items

Aug 15 · 11:25 StockStory
5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q2 Earnings Call
Aug 13 · 13:19 MT Newswires
Collegium Pharmaceutical Enters $50 Million Accelerated Share Repurchase Agreement
Aug 13 · 12:29 Motley Fool
Collegium Pharmaceutical (COLL) Q2 2026 Earnings Call Transcript
▸ Show all 21 press releases & news Free account →

Overview

52-week range
$23
$51
1% of range
Avg surprise (last 3)
+6.7%
Avg reaction (last 2)
+4.3%
100% positive
Latest IV / EM
33%
EM ±6.3% · $25 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.46$0.03$0.52$1.01$1.50 Actual $1.23Est $1.29Actual $1.47Est $1.43Actual $1.50Est $1.23Actual $-0.46 Mar/2025Jun/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-15M$41M$97M$154M$210M Mar 25Jun 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.46 — — — — financials
Thu May 7, 2026Mar/2026 $1.50 $1.23 +21.9% +21.9% +7.7% earnings
Thu Aug 7, 2025Jun/2025 $1.47 $1.43 +2.8% — — earnings
Thu May 8, 2025Mar/2025 $1.23 $1.29 -4.7% — +0.8% earnings

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$200M$194M——$188M$178M——
Cost of revenue$90M$76M——$80M$80M——
Gross profit$110M$117M——$108M$97M——
Operating income$4M$31M——$35M$22M——
Net income$-15M$14M——$12M$2M——
EPS (diluted)$-0.46$0.40——$0.34$0.07——

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$129M$269M$231M$150M$117M$96M$71M$39M
Inventory$113M$43M$41M$38M$38M$37M$36M$38M
Total current assets$608M$746M$691M$614M$549M$528M$482M$444M
Total assets$2.14B$1.65B$1.66B$1.61B$1.59B$1.63B$1.66B$1.64B
Long-term debt————————
Total liabilities$1.82B$1.34B$1.36B$1.33B$1.36B$1.40B$1.43B$1.40B
Total equity$312M$312M$302M$275M$232M$234M$229M$234M

Implied volatility — last 90 days

19%102%185%268%352% Jun 07 — IV 96% · EM ±13.3%Jun 08 — IV 105% · EM ±13.8%Jun 09 — IV 110% · EM ±13.8%Jun 10 — IV 45% · EM ±5.3%Jun 11 — IV 48% · EM ±5.3%Jun 19 — IV 78% · EM ±17.3%Jun 22 — IV 69% · EM ±14.3%Jun 24 — IV 57% · EM ±11.4%Jun 25 — IV 56% · EM ±11.1%Jun 26 — IV 71% · EM ±13.7%Jun 29 — IV 64% · EM ±11.3%Jun 30 — IV 91% · EM ±15.7%Jul 01 — IV 94% · EM ±15.7%Jul 02 — IV 123% · EM ±20.0%Jul 06 — IV 112% · EM ±15.5%Jul 07 — IV 88% · EM ±11.7%Jul 20 — IV 62% · EM ±14.6%Jul 21 — IV 64% · EM ±15.0%Jul 22 — IV 54% · EM ±12.5%Jul 23 — IV 70% · EM ±15.7%Jul 24 — IV 66% · EM ±14.5%Jul 27 — IV 69% · EM ±14.5%Jul 28 — IV 69% · EM ±14.1%Jul 29 — IV 68% · EM ±13.7%Jul 30 — IV 67% · EM ±13.1%Jul 31 — IV 63% · EM ±12.2%Aug 03 — IV 57% · EM ±10.1%Aug 04 — IV 60% · EM ±10.4%Aug 05 — IV 82% · EM ±13.8%Aug 10 — IV 143% · EM ±19.9%Aug 11 — IV 154% · EM ±20.4%Aug 13 — IV 77% · EM ±9.1%Aug 14 — IV 19% · EM ±2.1%Aug 17 — IV 143% · EM ±11.9%Aug 20 — IV 352% · EM ±14.7%Aug 24 — IV 117% · EM ±24.5%Aug 25 — IV 105% · EM ±21.5%Aug 26 — IV 77% · EM ±15.4%Aug 27 — IV 92% · EM ±18.0%Aug 28 — IV 33% · EM ±6.3%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in